Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for short-term outcomes in newborns with hypoxic ischemic encephalopathy
IRCT20160523028008N19Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in hypoxic-ischemic encephalopathy (HIE), sponsored by Hamadan University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
melatonin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on IRCT20160523028008N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N19.